Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments and dilemmas in renal transplantation

A H Wilkinson1, J T Rosenthal, G M Danovitch

  • 1Department of Medicine, UCLA School of Medicine, USA.

Advances in Renal Replacement Therapy
|April 1, 1994
PubMed
Summary

New immunosuppressive drugs show promise for reducing kidney transplant rejection and improving graft survival. Research explores novel therapies and compares them with standard protocols to enhance patient outcomes in transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living and deceased organ donation should be financially neutral acts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Organ transplantation for nonresidents of the United States: a policy for transparency.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Simultaneous liver-kidney transplantation summit: current state and future directions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Chain transplantation: initial experience of a large multicenter program.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011

Area of Science:

  • Transplantation immunology
  • Nephrology
  • Immunopharmacology

Background:

  • Significant disparity exists between kidney transplant demand and organ availability.
  • Acute rejection and chronic allograft nephropathy are major challenges in transplantation.
  • Cardiovascular disease and chronic liver disease pose risks for transplant candidates.

Purpose of the Study:

  • To review current immunosuppression protocols in kidney transplantation.
  • To highlight novel immunosuppressive drugs and antibody-induction therapies.
  • To discuss risk factors for graft loss, cardiovascular events, and liver disease in transplant recipients.

Main Methods:

  • Review of multicenter trials investigating new immunosuppressive drugs.
  • Comparison of antibody-induction therapy with standard immunosuppression regimens.
  • Analysis of risk factors for graft loss, cardiovascular disease, and hepatic inflammation.

Main Results:

  • Newer immunosuppressants targeting interleukin 2 and antimetabolites offer potential for improved outcomes.
  • Antibody-induction therapy presents an alternative to standard immunosuppression protocols.
  • Risk factors for accelerated graft loss, cardiovascular events in diabetic patients, and progressive liver disease are identified.

Conclusions:

  • Novel immunosuppressive agents and strategies hold promise for reducing acute rejection and prolonging kidney graft survival.
  • Careful management of immunosuppression, including cyclosporine dosing and prednisone withdrawal, is crucial.
  • Prophylaxis against cytomegalovirus (CMV) disease, particularly with ganciclovir during antibody therapy, is recommended.

Related Experiment Videos